Corbus
Is CORBUS undervalued?At only $450mcap is Corbus Pharmaceuticals undervalued?
1) Corbus is different from other cannabis stocks as they are designing therapies around marijuana to treat fibrotic diseases. If these therapies work, some analysts put the value of their potential sales at $2bn a year.
2) At a small marketcap of $450m, Corbus could be a real untouched gem in the cannabis industry, compared to its competitors with $4bn+ marketcap.
3) After an agreement with Japananese Kaken Pharmaceutical, Corbus is on the way to receive an additional $173m upon achievement of various milestones